{"id":"W4408099258","doi":"10.1182/bloodadvances.2024015086","title":"Nivolumab plus relatlimab for patients with relapsed or progressed B-cell malignancies in RELATIVITY-022","year":2025,"lang":"en","type":"article","venue":"Blood Advances","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency; Spinal Cord Injury BC; University Health Network","funders":"","keywords":"Nivolumab; Medicine; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006849401,0.0005248332,0.000698414,0.0001519071,0.000299314,0.0003772016,0.0003036069,0.0003107003,0.00130493],"category_scores_gemma":[0.0003589508,0.0002742527,0.000587787,0.0001503324,0.0002627186,0.0003074188,0.000304343,0.000851973,0.0004020804],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006020984,"about_ca_system_score_gemma":0.0006380593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006129523,"about_ca_topic_score_gemma":0.001428049,"domain_scores_codex":[0.9998196,0.00007462614,0.00001356778,0.00004340448,0.00001879411,0.00003004024],"domain_scores_gemma":[0.9998249,0.00002627858,0.00003761125,0.00001882717,0.00001077356,0.00008164192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2277471,0.01571384,0.1321286,0.001203529,0.001957051,0.003878905,0.0007822601,0.006271735,0.3031328,0.0005901167,0.006489765,0.3001043],"study_design_scores_gemma":[0.09034281,0.5044442,0.3155917,0.0001791817,0.001450279,0.009378177,0.0003126511,0.008505732,0.04485755,0.0004221375,0.0244002,0.0001154227],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975752,0.0007839295,0.0001917185,0.00009340228,0.00001919423,0.0001483024,0.0001498812,0.00003536702,0.001003024],"genre_scores_gemma":[0.9979649,0.00024087,0.0005433423,0.0001823473,0.00003044215,0.00009910903,0.0004053571,0.000008504918,0.0005252797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00130493,"threshold_uncertainty_score":0.004368544,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.007325588110520284,"score_gpt":0.2586844360969415,"score_spread":0.2513588479864212,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}